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Injury induced activation of extracellular signal-
regulated kinase (ERK) in the rat rostral
ventromedial medulla (RVM) is age dependant
and requires the lamina I projection pathway
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Abstract
Descending controls originating in part from the rostral ventromedial medulla (RVM) regulate the excitability of
dorsal horn neurons and maintain peripheral pain states. Activation of extracellular signal regulated kinase (ERK) in
RVM neurons has been shown following peripheral inflammation and is involved in generating the accompanying
inflammatory hyperalgesia. Here, we show that spared nerve injury (SNI), a model of neuropathic pain, results in an
increase in ERK activity in RVM neurons of adult rats 3 and 8 days following surgery. We carried out two experi-
mental procedures to demonstrate that this increase in ERK activation was related to the increased mechanical
sensitivity associated with SNI. First, we showed that lesions of the lamina I/III ascending pathway from the dorsal
horn attenuated both mechanical hyperalgesia and ERK activation in the RVM. Second, we performed SNI in P10
rats. At this age, SNI did not result in mechanical hypersensitivity, as previously shown, and did not activate ERK in
the RVM. Finally, the percentage of pERK expressing neurones that were also serotonergic was always around 60%,
independent of pain state and age, indicating an important role for serotonin in descending controls of pain
states.
Background
The rostral ventromedial medulla (RVM) plays an essen-
tial role in the regulation of spinal cord nociceptive
activity and pain transmission [1-5]. The RVM, inclusive
of the nucleus raphe magnus, nucleus reticularis gigan-
tocellularis and ventral nucleus reticularis gigantocellu-
laris, receives projections from the periaqueductal grey
and, in the adult rat, [5,6] activation of separate popula-
tions of RVM neurons generates either descending inhi-
bition or facilitation [7-10]. It has been shown that high
intensity stimulation within the RVM inhibited spinal
nociception while low intensity stimulation was facilita-
tory [6,11]. Finally, inactivation of the RVM with lido-
caine or excitatory block with the glutamate receptor
antagonist kynurenate lead to attenuation of mechanical
allodynia caused by inflammation or peripheral nerve
ligation respectively [12,13].
The Mitogen Activated Protein (MAP) kinases are
known to play an essential role in the regulation of neu-
ronal plasticity via post-translational and transcriptional
modifications. An increase in spinal extracellular signal-
related kinase (ERK) activity has been implicated in the
induction and/or maintenance of pain states following
noxious stimulation of the periphery [14-16]. Phospho-
ERK (pERK) was also up-regulated in the RVM follow-
ing peripheral inflammation induced by Complete
Freund’s Adjuvant (CFA)injected into the hind paw [17]
and inhibition of ERK signaling within the RVM some-
what reduced thermal hyperalgesia at 24 h (but not 7 h)
after inflammation [17,18].Although up-regulation of
pERK after digit amputation has been described in the
anterior cingulate cortex [19], the link between ERK
activity in the RVM and increased pain sensitivity in
models of neuropathic pain remains to be elucidated.
Descending controls from the RVM are indirectly
modulated by activity in ascending pathways originating
in lamina I/III projection neurons of the dorsal horn.
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significant attenuation of inflammation-induced hyperal-
g e s i aa n dn e u r o p a t h i cp a i n[ 2 0 , 2 1 ] .W eh a v et h e r e f o r e
investigated the influence of lamina I/III projection neu-
r o n e so nE R Ka c t i v a t i o ni nt h eR V Mi nb o t hn e u r o -
pathic and inflammatory pain models. We found that
ERK activation in the RVM is associated with mechani-
cal hyperalgesia but that both the pain states and pERK
expression are reduced by lamina I ablation.
Finally, it has been shown that young animals do
not develop neuropathic pain for at least 14 days post-
surgery [22]. Therefore, if ERK activation in the RVM
plays a crucial role in the maintenance of neuropathic
pain states, we hypothesized that ERK would not be
activated in the RVM of the young animal following
surgery. We found that this was indeed the case imply-
ing that activation of ERK in the RVM is correlated
with the development of neuropathic pain states.
Methods
Subjects
All procedures complied with the UK Animals (Scienti-
fic Procedures) Act 1986. Male Sprague Dawley rats
(P10 and 170-200 g; Central Biological Services, Univer-
sity College London, UK) were used for all experiments.
Animals were kept in their home cages at 21°C and 55%
relative humidity with a light-dark cycle of 12 h (lights
on at 08:00 h). Food and water were provided ad libi-
tum. All efforts were made to minimise animal suffering
and to reduce the number of animals used.
Antibodies and drugs
Anti- phospho p44/42 MAP kinase (ERK 1/2) (pERK;
Thr 202/Tyr 204) was obtained from Cell Signaling
Technology (Danvers, MA). Anti-tryptophan hydroxy-
lase (anti-TPH) was from Sigma (Poole, UK) and anti-
NK1 antibody was a gift from S. Vigna. Finally [Sar9,
Met(O2)11]substance P coupled to saporin (SSP-SAP)
from Advanced Targeting Systems (San Diego, CA) [23].
Ablation of lamina I projection neurons by intrathecal
injections of SSP-SAP
Rats under isoflurane anaesthesia (1.5-2% isoflurane
combined with 100% O2 (1l/min)) were placed in a
stereotaxic frame and a small incision was made in the
atlanto-occipital membrane. A cannula was inserted into
the subarachnoïd space, terminating in L4-5region.
Animals received either 10 μl( 1 0 0n g )o fS S P - S A Pi n
saline or 10 μlo fs a l i n e[ 2 3 ] .T h ec a n n u l aw a st h e n
withdrawn and the wound closed with sutures. Animals
were kept in their home cage for 4 weeks until further
experiment. The efficacy of SSP-SAP ablation was
assessed following NK1 immunohistochemistry.
Spared nerve injury surgery
The spared nerve injury (SNI) was performed as
described [24]. Under 2% isoflurane anaesthesia the
biceps femoris muscle was exposed and sectioned to
expose the sciatic nerve and its three terminal branches:
the sural, common peroneal and tibial nerves. The com-
mon peroneal and tibial nerves were tightly ligated with
5.0 silk and sectioned distal to the ligation. Care was
taken to avoid touching or stretching the spared sural
nerve. For sham surgery, the sciatic nerve was exposed
as described above but no contact was made with the
nerve.
Behavioural assay
Von-Frey test: mechanical sensitivity was assessed using
the Von-Frey test as described [25]. A series of cali-
brated Von-Frey hairs were applied to the lateral plantar
surface of the paw, in ascending order. The threshold
was taken as the lowest force required to elicit a
response to one of five repetitive stimuli.
Immunohistochemistry
For immunohistochemistry, rats were deeply anaesthe-
tized with pentobarbital and perfused transcardially as
described [26]. The spinal cord and brain were dissected
out, post-fixed in the same PFA 4% solution for 2 h and
transferred into a 30% sucrose solution in PB containing
0.01% azide, for a minimum of 24 h. Tissue was cut on
a freezing microtome at 40 μm. For pERK staining, free
floating tissue sections were blocked for 1 h in 3% nor-
mal goat serum and 0.3% triton X-100 in 0.1 M PB.
Tissue was then left to incubate in anti-pERK (1:250) in
TTBS for 3 days at 4°C. Biotinylated secondary antibody
was subsequently applied at a dilution of 1:400 in TTBS
for 1.5 h, followed by 30 min in avidin-biotin peroxidase
complex solution diluted to 1:250 of each Vectastain A
and Vectastain B solutions. A further tyramide signal
amplification step was performed at a dilution of 1:75
biotinylated tyramide in diluent (PerkinElmer LAS, Bos-
ton, MA) for 7 min. Sections were finally incubated
with FITC (Vector Laboratories, Burlingame, CA), 1:600
in TTBS for 2 h in a dark box. When double label with
TPH was required, the tissue was then placed in anti-
TPH (1:1000) overnight in the dark at room tempera-
ture. The following day, the sections were incubated for
2 h in Alexa Fluor 594 conjugated secondary antibody
(Invitrogen, Eugene, OR). After washing, sections were
mounted onto gelatinised slides. Once dry, slides were
coverslipped with Fluoromount (Sigma, UK) to minimise
any fading of fluorescence. Controls for double-staining
included omission of the second primary antibody. For
NK1 receptor staining, sections were incubated over-
night (1:5,000) at room temperature. On the following
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was applied followed by Cy3-streptavidin (1:4,000, 45
min). After final washes, sections were mounted as
described above.
Cell counting
The number of immunopositive cells expressing pERK
were counted bilaterally within the RVM using the ana-
tomical limits described by Imbe. et al. [17,18] (Fig. 1).
TPH was used as a marker to label serotonergic neu-
rones to define the RVM. Immunopositive cells were
counted and summed in the 5 RVM sections with the
most pERK labeling for each animal. The mean across
animals was used for further statistical analysis. Counts
of ERK activation within serotonergic neurons were also
done bilaterally within in the RVM.
Statistical data analysis
All statistical tests were performed in SPSS PC+. To ana-
lyse behavioural data, repeated measures ANOVA,
followed by Tukey or Bonferroni post-hoc analysis where
appropriate (SPSS+), was used. The Greenhouse-Geisser
‘ε’ correction was applied to compensate for any violation
of sphericity. Data were normalized by logarithmic (log2)
transformation. For pERK, pERK and TPH and NK1
receptor positive cells counting, the number of labeled
cells was analysed by univariate analysis with relevant
post-hoc analysis. Data were always analysed as presented
in the figures (raw data or log2 transformed).
Results
Phosphorylation of ERK in the RVM increases with
mechanical hypersensitivity in a model of neuropathic
pain, both in the induction and the maintenance phase
Adult rats were divided into three groups. Animals in
the first group were dedicated to behaviour testing: after
establishing mechanical thresholds using Von Frey fila-
ments, adult rats underwent SNI or sham surgery and
mechanical thresholds were measured for another
7 days. The other 2 groups of animals were dedicated to
histochemical analysis of pERK expression in the RVM:
animals underwent SNI or sham surgery and were
perfused on day 3 or on day 8 post-surgery.
As expected, adult rats having undergone SNI showed
increased mechanical sensitivity from day 2 to day
7 post- surgery (Fig.2A; F1,8 =1 5 . 9 ,P <0 . 0 1 ,S N Ivs
sham, day 2 today 7). Moreover, the number of pERK
positive cells within the RVM was greater in SNI ani-
mals when compared with sham animals both on day 3
(Fig. 2B; 200 ± 16 vs 143 ± 8 respectively, P < 0.05) and
day 8 post-surgery (Fig. 2B; 212 ± 6 vs 140 ± 7 respec-
tively, P < 0.01).
Ablation of NK1 receptor expressing neurones in the
dorsal horn reduces the expression of SNI induced pERK
in the RVM
We investigated the role of lamina I projection neurones
in the increase in mechanical sensitivity seen in SNI rats
and the associated activation of ERK in the RVM.
Animals received an intrathecal injection of SSP-SAP or
saline and 4 weeks later underwent SNI or sham surgery
(ie.a n i m a l sw e r eo r g a n i s e di n4g r o u p s :s a l i n es h a m ,
saline SNI, SSP-SAP sham and SSP-SAP SNI). Beha-
vioural testing began the day after surgery and contin-
ued until day 7 post-surgery. On day 8 post-surgery,
animals were perfused for pERK immunoreactivity ana-
lysis. Animals that underwent sham surgery showed no
decrease in mechanical sensitivity until at least day
7 (Fig. 3A). Mechanical thresholds of animals having
received saline SNI treatment significantly dropped from
day 2 post-surgery and remained decreased until
day 7 (Fig. 3A). However, when animals received an
pERK / RVM
RMg
Py
GiA
Figure 1 pERK expression in the RVM after SNI surgery. RMg: nucleus raphe magnus; GiA: nucleus reticularis gigantocellularis pars alpha; Py:
pyramidal tract. Scale bar, 200 μm.
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Page 3 of 9SSP-SAP injection prior to the SNI surgery, there was
no decrease in mechanical sensitivity on day 2 and day
4 of testing and at day 7 their mechanical threshold was
still significantly higher than that of the saline pre-trea-
ted group (Fig. 3A; F1,8 = 16.7, P < 0.01, post-hoc SSP-
SAP SNI vs saline SNI). When we counted the number
of pERK expressing cells within the RVM day 8 post
SNI surgery, there was no difference between the 2
sham operated groups and results were pooled together
(Fig. 3B; 134 ± 7).There was a significant increase in
pERK expression when animals had received saline SNI
treatment, both compared to SSP-SAP SNI and sham
W
i
t
h
d
r
a
w
a
l
 
t
h
r
e
s
h
o
l
d
 
(
l
o
g
2
(
g
)
,
 
1
/
5
 
w
i
t
h
d
r
a
w
a
l
)
bs1 bs2 day2 day4 day7
7
6
5
4
3
2
1
0
Adults
Sham
SNI
**
A B Adults
S
u
m
 
o
f
 
t
h
e
 
n
u
m
b
e
r
 
o
f
 
p
E
R
K
-
I
R
 
c
e
l
l
s
 
i
n
 
t
h
e
5
 
m
o
s
t
 
l
a
b
e
l
e
d
 
s
e
c
t
i
o
n
s
 
o
f
 
t
h
e
 
R
V
M
Sham SNI
day3 day8
200
160
120
80
40
0
240
Sham SNI
* **
Figure 2 Phosphorylation of ERK in the RVM increases with mechanical sensitivity in a model of neuropathic pain. Effects of SNI or
sham surgery in adult rats (N = 4-5 in each group) on: A/Mechanical withdrawal thresholds measured by Von Frey testing of the hind paw of
the operated limb; and B/pERK expression in the RVM 3 and 8 days after surgery. Adult rats developed mechanical hypersensitivity and showed
increase ERK activation in the RVM at 3 and 8 days post-SNI. Data show mean ± SEM. * P < 0.05, ** P < 0.01.
Figure 3 Ablation of NK1 receptor expressing neurones in the dorsal horn reduces SNI induced decrease in mechanical threshold and
ERK phosphorylation in the RVM. Effect of SSP-SAP or saline intrathecal injections on: A/mechanical threshold following SNI surgery measured
by Von Frey testing and B/SNI induced pERK expression in the RVM 8 days after SNI surgery. SSP-SAP treatment significantly attenuated both the
SNI induced hyperalgesia and the SNI induced ERK activation in the RVM. N = 3-5 in each group. Data show mean ± SEM. * P < 0.05, ** P < 0.01.
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174 ± 7 vs 134 ± 7, P <0 . 0 1 ,s a l i n eS N Ivs SSP-SAP
SNI and saline SNI vs sham respectively).
Intrathecal injection of SSP-SAP reduces NK1 receptor
expression in the superficial dorsal horn
To confirm that NK1 receptor immunoreactivity was
reduced in the dorsal horn following SSP-SAP treatment
we processed tissue from each of the rats described in
the experiment above. Immunostaining for the NK1
receptor showed a marked reduction inimmunofluores-
cence when animals had received SSP-SAP treatment
(Fig. 4A-D).
P10 rats do not develop neuropathic pain and do not
show any increase in pERK expression in the RVM
following SNI
After establishing mechanical thresholds by Von Frey
testing, P10 rats underwent SNI, sham surgery or were
put under isoflurane anaesthesia. Mechanical thresholds
were measured for another 7 days and on day 8 animals
were perfused for histochemical analysis of pERK
expression in the RVM. P10 animals have been shown
not to develop neuropathic pain and indeed we found
no difference in mechanical threshold between naïve,
sham and SNI until day 7 following surgery (Fig. 5A).
Moreover, when we analysed pERK staining within the
RVM for these animals 8 days following surgery (P18
animals) we did not find any differences between the 3
groups of animals (Fig. 5B; number of pERK labelled
cells within the RVM: 97 ± 16, 90 ± 9 and 75 ± 8,
naïve, sham and SNI respectively).
ERK activation in the RVM is mainly within 5HT
expressing neurones and the proportion of 5HT/pERK
positive neurons does not change with pain state or age
There was no difference in the number of pERK positive
neurons in the serotonergic population between sham
and SNI animals in P18 rats, 52% ± 5% and 56% ± 4%
of pERK expressing neurones were serotonergic,
Figure 4 Intrathecal injection of SSP-SAP reduces NK1 receptor expression in the superficial dorsal horn. Effect of SSP-SAP or saline
intrathecal injections on NK1 receptor expression in the superficial dorsal horn. A, B/Confocal images of NK1 receptor immunohistochemistry in
lamina I of SNI animals after SSP-SAP or saline treatment. C,D/Confocal images of NK1 receptor immunohistochemistry in lamina III of SNI
animals after SSP-SAP or saline treatment. All images taken from the dorsal horn. contralateral to SNI. Arrows show cell bodies within lamina III.
Scale bar, 100 μm.
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expressing neurones also remained constant in adult
rats after SNI or sham surgery, with saline or SSP-SAP
pre-treatment: saline sham: 60% ± 1%, SSP-SAP sham:
61% ± 3%, saline SNI: 57% ± 4% and SSP-SAP SNI: 62%
± 3%. Fig. 6 shows double neurones labelled for pERK
and 5HT in the RVM of adult rats following SNI.
Discussion
Here, we show that ERK is activated within the adult
RVM during both the induction and the maintenance
phase of a neuropathic pain state. This activation is cor-
related with the mechanical hypersensitivity that follows
tissue injury. Two experiments strongly implied that
pERK was causally related to increased mechanical sen-
sitivity. First, ablation of lamina I projection neurones
attenuated the activation of ERK in the RVM after SNI
surgery, as well as the induced mechanical hypersensi-
tivity. Second, SNI in neonatal rats did not activate ERK
in the RVM and there was no mechanical hyperalgesia.
In the present study, we investigated the activation of
ERK within the RVM after tissue injury at different time
points corresponding to induction and maintenance of
the pain state. We investigated ERK activation in the
adult RVM 3 and 8 days following SNI and found that
pERK was elevated compared to SHAM to the same
Figure 5 P10 rats do not develop neuropathic pain and do not show any increase in pERK expression in the RVM following SNI.
Effects of SNI or sham surgery in P10 rats (N = 3 in each group), on: A/Mechanical withdrawal thresholds measured by Von Frey testing of the
hind paw of the operated limb; and B/pERK expression in the RVM, 8 days after surgery. P10 rats never developed mechanical hypersensitivity
and there was no difference in pERK expression in their RVM. Data show mean ± SEM.
Figure 6 60% of pERK expressing neurons in the RVM are also serotonergic. Confocal images of ERK activation in the RVM 8 days post-SNI
surgery. Colocalization of ERK expressing neurons (green) and TPH expressing neurones (red). The single staining for each antibody and the
merged image are shown from left to right and double staining appears in yellow. Notice the extensive staining of dendrites (arrow heads).
Arrows show non double labeled neurons. Scale bar, 200 μm.
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following SNI surgery, the number of pERK expressing
neurones was 1.5 times higher than that in sham. This
indicated that ERK remains activated within the RVM
and may be important in maintaining the pain state. In
our study, 8 days post SNI surgery, pERK expression
within the RVM was limited to neurons and no glial
activation was seen. p38, another MAPK involved in the
maintenance of pain states, was found in microglia in
the RVM 3 h after carrageenan injection into the hind-
paw [27]. However, we did not find pERK within micro-
glia or astrocytes, 8 days post SNI in the RVM (data not
shown).
Interestingly, we also found that the proportion of
pERK neurones labelled with TPH did not change after
nerve injury although the total number of labelled neu-
rons increased with treatment. In contrast, others have
reported that the proportion of pERK neurons positive
for 5HT increased from 30% to 60% 7 h after CFA
injection (3% and 20% of the 5HT positive neurones
respectively) [17]. However, it is important to notice
that in this later study control animals were completely
naïve (i.e. had receive no injection and were not put
under anaesthesia) whereas in the present study control
animals always underwent a sham operation.
Nevertheless, our results strongly imply that 5HT-
positive RVM neurons are recruited during inflamma-
tory and neuropathic pain states although this is always
alongside a similar proportion of non-5HT positive neu-
rons. Previous studies have indeed indicated that both
RVM 5HT-dependent and -independent mechanisms
regulate dorsal horn sensitivity and specific ablation of
RVM 5HT neurons has been shown to modulate both
electrical stimulation and BDNF induced hyperalgesia
but not opiate induced analgesia [28]. RVM cells have
previously been classified into 3 groups: ON-, OFF- and
NEUTRAL- cells and it is believed that ON- and OFF-
cells are recruited to engage respectively descending
facilitation and inhibition from the brainstem [8,29,30].
Although only NEUTRAL- cells have been reported to
contain 5HT [31], ON- and OFF cells have been shown
to receive a strong serotonergic innervation, indicating
that serotonin could both directly and indirectly control
pain processing at the brainstem and spinal level
[32,33]. Also, some serotonergic neurons express the
mu opiate receptor [34] which has previously been sug-
gested to be characteristic of non-5HT ON- cells. Speci-
fic ablation of RVM mu receptor expressing neurons by
dermorphin-saporin conjugates alleviated pain states
and would be expected to lesion both subsets of 5HT
and non-5HT containing ON- cells. Descending 5HT
projections from the RVM have been shown to contri-
bute to the maintenance of chronic pain states at the
5HT3 receptor expressed by dorsal horn and primary
afferent neurons [35-37]. Finally, there is evidence
to suggest that NEUTRAL- cells (and therefore seroto-
nergic neurons) can be recruited to become ON- or
OFF- cells in persistent pain states [38] reinforcing the
serotonergic contribution to descending modulation.
The role of pERK activation in RVM at 3 days post
SNI is not clear. Previous results have shown that RVM
is essential for the maintenance but not induction of
mechanical hyperalgesia following peripheral nerve
manipulations [39]. It seems likely that primary afferent
activity following SNI is of particular importance in
inducing the neuropathic pain state but that mainte-
nance requires pERK activity in RVM neurons. How-
ever, given the high basal levels of pERK reported here,
it is unlikely that direct injections of ERK inhibitors into
the RVM would resolve this issue.
To test the hypothesis that ERK phosphorylation in
the RVM is correlated with increased mechanical sensi-
tivity, we investigated the influence of lesions of lamina
I/III projection neurons with SSP-SAP. Previous
research has shown that ablation of lamina I/III projec-
tion neurons attenuated most inflammatory and neuro-
pathic pain states and that both induction and
maintenance phases are reduced [20]. It was also shown
that the immediate-early gene c-fos was up-regulated in
the RVM following formalin injection into the hind paw
and that this was reduced by lamina I/III lesions [36].
We therefore hypothesized that the loss of mechanical
hypersensitivity in neuropathic pain states following
ablation of lamina I/III projection neurons would be
accompanied by reduced ERK activation in the RVM.
Indeed, we found that ablation of lamina I/III projection
neurons substantially reduced the activation of ERK in
RVM neurons 8 days post surgery.
In a second set of experiments, we tested, in rat pups,
the hypothesis that ERK phosphorylation in the RVM is
correlated with hyperalgesia. Neonates do not develop
mechanical hypersensitivity following the SNI procedure
[22]. We therefore postulated that if ERK activation in
the RVM and neuropathic sensitivity were linked, we
would not see increased levels of pERK in the RVM of
neonates that had undergone SNI. This was the case
and there could be a number of reasons for this. First, it
might be that the lamina I/III projection pathway is
itself non-functional at birth. However, using c-fos
histochemistry it has been possible to show that the
lamina I/III-parabrachial nucleus projection neurones
pathway is intact and functional in newborn rats. Dorsal
horn neurones are responsive to noxious stimulation at
P3 and capable of activating neurons within the parabra-
chial nucleus [40]. Therefore the absence of ERK activa-
tion within the RVM of neonates following SNI surgery
is unlikely to be explained by the developmental state of
ascending pathways. However, lamina I/III projection
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but through intermediate targets such as the PAG. It
seems likely that the changing postnatal influence of the
RVM in spinal nociception and the late development of
the PAG-RVM connection [11,41] may account for the
failure of SNI to promote mechanical hyperalgesia in
neonates following peripheral nerve injury. This later
point is of importance when considering the route by
which RVM neurons are activated. One suggestion is
through a connection between the PAG and the RVM
known to release brain-derived neurotrophic factor
(BDNF). Microinjection of BDNF into the RVM facili-
tates nociception. This action of BDNF is dependent on
NMDA receptors and both inflammatory hyperalgesia
and neuropathic pain can be inhibited by RVM injec-
tions of NMDA receptor antagonists [42,43]. BDNF has
been shown in other systems to activate ERK [44] and a
role of released BDNF in the activation of ERK in the
RVM seems likely.
Conclusions
In summary, we show that ERK activation in the RVM
is correlated with increased mechanical hypersensitivity
in a neuropathic pain model and is mediated by the
lamina I/III dorsal horn projection pathway. We also
show that there is a contribution of 5HT neurons to
this process but always in concert with the activation of
significant numbers of non-serotonergic RVM neurons.
Abbreviations
SNI: Spared Nerve Injury; ERK: Extracellular Signal Regulated Kinase; RVM:
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